Cancer Therapy News and Research

RSS

More frequent post treatment monitoring does not improve survival in prostate cancer patients, finds study

FDA approves first Neulasta biosimilar to help decrease infection risk during cancer treatment

The U.S. Food and Drug Administration today approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to decrease the chance of infection as suggested by febrile neutropenia (fever, often with other signs of infection, associated with an abnormally low number of infection-fighting white blood cells), in patients with non-myeloid (non-bone marrow) cancer who are receiving myelosuppressive chemotherapy that has a clinically significant incidence of febrile neutropenia.

4 Jun 2018

Vigorous exercise linked with reductions in mortality risk for adult survivors of childhood cancer

Vigorous exercise is associated with reductions in the risk of death among adult survivors of childhood cancer.

4 Jun 2018

Researchers identify racial differences in breast cancer immune microenvironment

Roswell Park Comprehensive Cancer Center researchers have identified significant differences in the immune microenvironment of breast cancer tumors between African-American and white women, shedding light on the ways in which race can influence cancer development and outcomes.

4 Jun 2018

Study finds increase in lifestyle-related cancers over the past decade

Lifestyle-related cancers, such as lung, colorectal, and skin cancers, have increased globally over the past decade, according to the most comprehensive analysis of cancer-related health outcomes and patterns ever conducted.

4 Jun 2018

Phase I trial shows safety of investigational drug in treating chronic lymphocytic leukemia

Reporting results from a first-in-human phase I clinical trial, researchers at University of California San Diego School of Medicine have found that treatment with cirmtuzumab, an experimental monoclonal antibody-based drug, measurably inhibited the "stemness" of chronic leukemia cancer cells - their ability to self-renew and resist terminal differentiation and senescence.

1 Jun 2018

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Bristol-Myers Squibb Company today announced patient-reported outcomes data from the Phase 3 CheckMate -214 trial in intermediate- and poor-risk patients with advanced renal cell carcinoma treated with the Immuno-Oncology combination Opdivo plus low-dose Yervoy versus sunitinib over a two-year follow-up period.

1 Jun 2018

ORNL increases production of actinium-227 to meet demand for cancer drug

The Department of Energy's Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.

1 Jun 2018

RaySearch signs research collaboration agreement with NIRS/QST for advancement of ion beam therapy

RaySearch has signed a research collaboration and licensing agreement with the National Institutes for Quantum and Radiological Science and Technology, a pioneer of ion beam technology based in Chiba, Japan. QST was established in 2016 when the National Institute of Radiological Sciences was merged with certain functions of the Japan Atomic Energy Agency.

31 May 2018

Scientists introduce combination approach to fight cancer

For efficient cancer therapy with few side effects, the active drug should selectively attain high concentration in the tumor. In the journal Angewandte Chemie, scientists have introduced a new approach, in which two synergistic drug components are combined into a dimer.

31 May 2018

Male thyroid cancer survivors face nearly 50% higher CVD risk than women, study suggests

Male thyroid cancer survivors have a nearly 50 percent higher risk of developing heart disease than women within five years of cancer diagnosis, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

30 May 2018

Scientists develop a new approach for efficient cancer therapy

For efficient cancer therapy with few side effects, the active drug should selectively attain high concentration in the tumor.

30 May 2018

Olfactory receptor in human bladder might prove useful for bladder cancer therapy, diagnosis

Researchers from Bochum have detected an olfactory receptor in the human bladder that might prove useful for bladder cancer therapy and diagnosis.

29 May 2018

UCI Center on Stress & Health receives NIH funding to develop digital health interventions

Researchers at the University of California, Irvine's Center on Stress & Health have received $6.3 million in grants from the National Institutes of Health to develop and test digital health interventions for stress and pain in children facing surgical procedures and those battling cancer.

26 May 2018

Study establishes the importance of haploid cells

A new study has found that when the cell replication process exceeds or has less than a pair of chromosome set (a genome), destabilization occurs.

25 May 2018

Cancer cells co-opt pain-sensing 'neural channel' to increase tolerance against oxidative stress

Anyone who's taken a bite of a sandwich with too much spicy mustard or a piece of sushi with too much wasabi can attest to the tear-inducing sensation these condiments can cause. These loud warnings to the nervous system of exposure to potentially harmful chemicals are triggered by TRPA1, a calcium channel protein sometimes referred to as the "wasabi receptor."

25 May 2018

Research examines link between lower-fat diet and breast cancer overall survival

Women diagnosed with breast cancer during the Women's Health Initiative Dietary Modification trial who were following a lower-fat diet had increased breast cancer overall survival, although the increase was likely partly due to better survival from several causes of death.

24 May 2018

Cancer Therapy News and Research

More frequent post treatment monitoring does not improve survival in prostate cancer patients, finds study

FDA approves first Neulasta biosimilar to help decrease infection risk during cancer treatment

Vigorous exercise linked with reductions in mortality risk for adult survivors of childhood cancer

Researchers identify racial differences in breast cancer immune microenvironment

Study finds increase in lifestyle-related cancers over the past decade

Phase I trial shows safety of investigational drug in treating chronic lymphocytic leukemia

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

ORNL increases production of actinium-227 to meet demand for cancer drug

RaySearch signs research collaboration agreement with NIRS/QST for advancement of ion beam therapy

Scientists introduce combination approach to fight cancer

Male thyroid cancer survivors face nearly 50% higher CVD risk than women, study suggests

Scientists develop a new approach for efficient cancer therapy

Olfactory receptor in human bladder might prove useful for bladder cancer therapy, diagnosis

UCI Center on Stress & Health receives NIH funding to develop digital health interventions

Study establishes the importance of haploid cells

Cancer cells co-opt pain-sensing 'neural channel' to increase tolerance against oxidative stress

Research examines link between lower-fat diet and breast cancer overall survival

Two genes play vital roles in malignant brain cancer

International researchers succeed in stopping growth of mesothelioma in model animals

Researchers to test two-pronged approach in humans to treat advanced colorectal cancer

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News